EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against Toxoplasma gondii through an in-silico approach

Ali Dalir Ghaffari iD, Abdolhossein Dalimi iD, Fatemeh Ghaffarifar iD, Majid Pirestani iD, Hamidreza Majidiani iD

Clinical and Experimental Vaccine Research · 2021 · 10 (1) · 59

DOI: 10.7774/cevr.2021.10.1.59 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Vaccine Research, 2021. Verfasst von Ali Dalir Ghaffari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tarbiat Modares University, Iran National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Toxoplasmosis, transmitted by Toxoplasma gondii, is a worldwide parasitic disease that affects approximately one-third of the world's inhabitants. Today, there are no appropriate drugs to deter tissue cysts from developing in infected hosts. So, developing an effective vaccine would be valuable to avoid from toxoplasmosis. Considering the role of microneme antigens such as microneme protein 4 (MIC4) in T. gondii pathogenesis, it can be used as potential candidates for vaccine against T. gondii. MATERIALS AND METHODS: In this study several bioinformatics methods were used to assess the different aspects of MIC4 protein such as secondary and tertiary structure, physicochemical characteristics, the transmembrane domains, subcellular localization, B-cell, helper-T lymphocyte, cytotoxic-T lymphocyte epitopes, and other notable characteristic of this protein design a suitable vaccine against T. gondii. RESULTS: The studies revealed that MIC4 protein includes 59 potential post-translational modification sites without any transmembrane domains. Moreover, several probable epitopes of B- and T-cells were detected for MIC4. The secondary structure comprised 55.69% random coil, 5.86% beta-turn, 19.31% extended strand, and 19.14% alpha helix. According to the Ramachandran plot results, 87.42% of the amino acid residues were located in the favored, 9.44% in allowed, and 3.14% in outlier regions. The protein allergenicity and antigenicity revealed that it was non-allergenic and antigenic. CONCLUSION: This study gives vital basic on MIC4 protein for further research and also established an effective vaccine with different techniques against acute and chronic toxoplasmosis.

Schlagwörter

Stichwörter der Autor:innen

BioinformaticsMIC4 proteinToxoplasma gondiiVaccine

Autor:innen und Institutionen

  • Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

ORCID-Profile: Ali Dalir Ghaffari, Abdolhossein Dalimi, Fatemeh Ghaffarifar, Majid Pirestani, Hamidreza Majidiani

Förderung

  • Tarbiat Modares University
  • Iran National Science Foundation

Zitieren

APA

Ghaffari, A. D., Dalimi, A., Ghaffarifar, F., Pirestani, M., & Majidiani, H. (2021). Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against Toxoplasma gondii through an in-silico approach. Clinical and Experimental Vaccine Research, 10(1), 59. https://doi.org/10.7774/cevr.2021.10.1.59

Vancouver

Ghaffari AD, Dalimi A, Ghaffarifar F, Pirestani M, Majidiani H. Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against Toxoplasma gondii through an in-silico approach. Clinical and Experimental Vaccine Research. 2021;10(1):59. doi:10.7774/cevr.2021.10.1.59

BibTeX
@article{Ghaffari2021,
  author = {Ghaffari, Ali Dalir and Dalimi, Abdolhossein and Ghaffarifar, Fatemeh and Pirestani, Majid and Majidiani, Hamidreza},
  title = {Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against Toxoplasma gondii through an in-silico approach},
  journal = {Clinical and Experimental Vaccine Research},
  year = {2021},
  volume = {10},
  number = {1},
  pages = {59},
  doi = {10.7774/cevr.2021.10.1.59}
}
Kostenlos starten →